Biosimilar drug development
The company is also active in developing biosimilar medicines.
Source: LinkedIn company description · Retrieved October 13, 2026
Richter Gedeon’s product portfolio covers therapeutic areas including gynecology, the central nervous system, and cardiovascular diseases.
Gedeon Richter Plc is headquartered in Budapest, Hungary, and has a direct presence in Central and Eastern Europe, with growing direct presence in Western Europe, China, and Latin America. Richter Gedeon’s representative office in Serbia opened in 2007.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is also active in developing biosimilar medicines.
Source: LinkedIn company description · Retrieved October 13, 2026
Richter Gedeon has expertise in synthesizing and manufacturing sex hormones.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026 and September 16, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.